Results 51 to 60 of about 4,196 (141)

Anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine and associated factors in Japanese hemodialysis patients [PDF]

Kidney Research and Clinical Practice
Background We assessed the anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine in Japanese hemodialysis patients and determined factors associated with the anti-SARS-CoV-2 spike antibody titer after the third dose ...
Keiji Hirai, Masako Shimotashiro, Toshiaki Okumura, Susumu Ookawara, Yoshiyuki Morishita   +4 more
doaj   +1 more source

SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study

Viruses, 2022
Studies assessing the dynamics and duration of antibody responses following SARS-CoV-2 infection or vaccination are an invaluable tool for vaccination schedule planning, assessment of risk groups and management of pandemics.
Paola Kučan Brlić, Martina Pavletić, Mate Lerga, Fran Krstanović, Marina Pribanić Matešić, Karmela Miklić, Suzana Malić, Leonarda Mikša, Maja Pajcur, Dolores Peruč, Maren Schubert, Federico Bertoglio, Jurica Arapović, Alen Protić, Alan Šustić, Marko Milošević, Luka Čičin Šain, Stipan Jonjić, Vanda Juranić Lisnić, Ilija Brizić   +19 more
doaj   +1 more source

Evidence–time dilemma in a pandemic with high mortality: Can outcome‐driven decision making on vaccines prevent deaths?

, 2022
Clinical and Translational Science, Volume 15, Issue 1, Page 5-8, January 2022.
Klaus Eckhardt
wiley   +1 more source

Data Resource Profile: COVid VAXines Effects on the Aged (COVVAXAGE)

International Journal of Population Data Science, 2023
Background To improve the assessment of COVID-19 vaccine use, safety, and effectiveness in older adults and persons with complex multimorbidity, the COVid VAXines Effects on the Aged (COVVAXAGE) database was established by linking CVS Health and ...
Kaleen Hayes, Daniel Harris, Andrew Zullo, Djeneba Audrey Djibo, Renae L. Smith-Ray, Michael S. Taitel, Tanya G. Singh, Cheryl McMahill-Walraven, Preeti Chachlani, Katherine Wen, Ellen P. McCarthy, Stefan Gravenstein, Sean McCurdy, Kristina E. Baird, Daniel Moran, Derek Fenson, Yalin Deng, Vincent Mor   +17 more
doaj   +1 more source

Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection

Frontiers in Immunology, 2023
IntroductionWe investigated humoral and T-cell responses within 12 months after first BNT162b2 vaccine in solid organ transplant (SOT) recipients and controls who had received at least three vaccine doses.
Omid Rezahosseini, Sebastian Rask Hamm, Line Dam Heftdal, Laura Pérez-Alós, Dina Leth Møller, Michael Perch, Michael Perch, Johannes Roth Madsen, Annemette Hald, Cecilie Bo Hansen, Jose Juan Almagro Armenteros, Mia Marie Pries-Heje, Rasmus Bo Hasselbalch, Rasmus Bo Hasselbalch, Kamille Fogh, Kamille Fogh, Ruth Frikke-Schmidt, Ruth Frikke-Schmidt, Linda Maria Hilsted, Erik Sørensen, Sisse Rye Ostrowski, Sisse Rye Ostrowski, Zitta Barrella Harboe, Zitta Barrella Harboe, Zitta Barrella Harboe, Kasper Iversen, Kasper Iversen, Kasper Iversen, Henning Bundgaard, Henning Bundgaard, Søren Schwartz Sørensen, Søren Schwartz Sørensen, Allan Rasmussen, Peter Garred, Peter Garred, Susanne Dam Nielsen, Susanne Dam Nielsen   +36 more
doaj   +1 more source

Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics

, 2021
Clinical and Translational Medicine, Volume 11, Issue 1, January 2021.
Shan Su, Qian Wang, Shibo Jiang
wiley   +1 more source

Neutralizing Activity and SARS-CoV-2 Vaccine mRNA Persistence in Serum and Breastmilk After BNT162b2 Vaccination in Lactating Women

Frontiers in Immunology, 2022
BackgroundThere is limited information on the functional neutralizing capabilities of breastmilk SARS-CoV-2-specific antibodies and the potential adulteration of breastmilk with vaccine mRNA after SARS-CoV-2 mRNA vaccination.MethodsWe conducted a ...
Kee Thai Yeo, Kee Thai Yeo, Kee Thai Yeo, Wan Ni Chia, Chee Wah Tan, Chengsi Ong, Chengsi Ong, Joo Guan Yeo, Joo Guan Yeo, Joo Guan Yeo, Jinyan Zhang, Su Li Poh, Amanda Jin Mei Lim, Kirsten Hui Zhi Sim, Nursyuhadah Sutamam, Camillus Jian Hui Chua, Salvatore Albani, Salvatore Albani, Lin-Fa Wang, Lin-Fa Wang, Mei Chien Chua, Mei Chien Chua, Mei Chien Chua, Mei Chien Chua   +23 more
doaj   +1 more source

Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study

Vaccines, 2022
This study aimed to evaluate the mixed and homogeneous application of the inactivated SARS-CoV-2 vaccine CoronaVac (CV) and the mRNA vaccine BNT162b2 (BNT).
Hakan Demirhindi, Burak Mete, Ferdi Tanir, Ertan Kara, Filiz Kibar, Salih Cetiner, Aslihan Candevir, Sukriye Ece Akti   +7 more
doaj   +1 more source

Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18–30 Years Old): An Independent Post-Marketing Study

Pharmaceuticals, 2021
Young adults had been widely perceived as a low-risk group for COVID-19 severity; therefore, they were deprioritised within the mass vaccination strategies as their prognosis of COVID-19 infection is relatively more favourable than older age groups.
Abanoub Riad, Andrea Pokorná, Jitka Klugarová, Natália Antalová, Lucia Kantorová, Michal Koščík, Miloslav Klugar   +6 more
doaj   +1 more source

Respiratory virus mRNA vaccines: mRNA Design, clinical studies, and future challenges

Animal Models and Experimental Medicine, Volume 8, Issue 10, Page 1731-1740, October 2025.
Abstract Respiratory infectious diseases frequently erupt on a global scale, with RNA viruses, such as SARS‐CoV‐2, RSV, and influenza viruses, posing challenges to vaccine development due to their high mutation rates. Traditional vaccine development cycles are lengthy and struggle to keep pace with rapidly evolving viruses, whereas messenger RNA (mRNA)
Linlin Zheng, Han Feng
wiley   +1 more source